To further investigate the clinical prognostic value of E2Fs in PCa patients, a stepwise regression analysis was performed, and E2F1 and E2F6 were identified to predict the disease-free survival of prostate cancer together with Gleason score and tumor stage. This evidence concerns the gene E2F1 and prostate carcinoma.